X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4146) 4146
Publication (228) 228
Newsletter (83) 83
Book Review (62) 62
Magazine Article (26) 26
Book Chapter (7) 7
Newspaper Article (7) 7
Trade Publication Article (2) 2
Transcript (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3415) 3415
colchicine - therapeutic use (2841) 2841
male (1748) 1748
colchicine (1726) 1726
female (1525) 1525
adult (1138) 1138
index medicus (1138) 1138
middle aged (935) 935
animals (572) 572
familial mediterranean fever - drug therapy (569) 569
rheumatology (549) 549
gout suppressants - therapeutic use (534) 534
aged (531) 531
gout - drug therapy (506) 506
treatment outcome (482) 482
familial mediterranean fever (473) 473
medicine, general & internal (380) 380
adolescent (366) 366
anti-inflammatory agents, non-steroidal - therapeutic use (347) 347
gout (340) 340
colchicine - administration & dosage (321) 321
pharmacology & pharmacy (320) 320
child (311) 311
drug therapy, combination (299) 299
anti-inflammatory agents - therapeutic use (296) 296
colchicine - adverse effects (294) 294
colchicine - pharmacology (291) 291
therapy (278) 278
familial mediterranean fever - complications (276) 276
care and treatment (256) 256
immunosuppressive agents - therapeutic use (241) 241
adrenal cortex hormones - therapeutic use (240) 240
diagnosis, differential (237) 237
acute disease (236) 236
recurrence (234) 234
behcet syndrome - drug therapy (229) 229
familial mediterranean fever - diagnosis (226) 226
allopurinol - therapeutic use (224) 224
arthritis (222) 222
tubulin modulators - therapeutic use (218) 218
disease (214) 214
familial mediterranean fever - genetics (214) 214
rats (210) 210
management (207) 207
diagnosis (204) 204
inflammation (198) 198
mice (197) 197
time factors (188) 188
uric acid - blood (188) 188
drug therapy (185) 185
amyloidosis (182) 182
double-blind (181) 181
research (172) 172
risk factors (171) 171
amyloidosis - drug therapy (164) 164
follow-up studies (160) 160
cardiac & cardiovascular systems (157) 157
abridged index medicus (155) 155
prognosis (155) 155
dermatology (154) 154
medicine & public health (151) 151
analysis (150) 150
health aspects (150) 150
pericarditis - drug therapy (150) 150
child, preschool (148) 148
mutation (147) 147
young adult (147) 147
gout - diagnosis (146) 146
glucocorticoids - therapeutic use (145) 145
prednisone - therapeutic use (138) 138
cancer (137) 137
retrospective studies (136) 136
amyloidosis - etiology (129) 129
children (129) 129
chronic disease (125) 125
dose-response relationship, drug (124) 124
prevention (123) 123
tubulin (121) 121
pyrin (117) 117
medicine (116) 116
tubulin - metabolism (115) 115
antineoplastic agents - therapeutic use (113) 113
behcet syndrome - complications (113) 113
double-blind method (112) 112
pediatrics (112) 112
gout - complications (111) 111
genetic aspects (110) 110
research article (110) 110
trial (110) 110
apoptosis (109) 109
fever (108) 108
allopurinol (107) 107
internal medicine (107) 107
clinical trials as topic (105) 105
pericarditis (104) 104
corticosteroids (103) 103
hyperuricemia (102) 102
biopsy (101) 101
surgery (100) 100
aged, 80 and over (99) 99
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3589) 3589
French (209) 209
German (146) 146
Italian (71) 71
Spanish (66) 66
Russian (49) 49
Japanese (38) 38
Dutch (23) 23
Hebrew (13) 13
Polish (9) 9
Danish (8) 8
Czech (7) 7
Romanian (7) 7
Chinese (6) 6
Hungarian (6) 6
Portuguese (6) 6
Bulgarian (4) 4
Finnish (3) 3
Norwegian (3) 3
Croatian (2) 2
Korean (2) 2
Serbian (2) 2
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 10/2016, Volume 26, Issue 10, pp. 1157 - 1174
Introduction: Colchicine, the major alkaloid extracted from the meadow saffron (Colchicum autumnale) is one of the most prominent natural products belonging to... 
toxicity | Colchicine | concomitant administration | secondary use | gout | CHEMISTRY, MEDICINAL | PHARMACOLOGY & PHARMACY | HISTORY
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2014, Volume 35, Issue 27, pp. 1782 - 1791
Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in the arterial wall. Rather, the initiation and progression of... 
Darapladib | Atherosclerosis | Inflammasome | Inflammation | Colchicine | Salsalate | C reactive protein | Canakinumab | Methotrexate | Interleukin-6 | C-REACTIVE PROTEIN | FUTURE MYOCARDIAL-INFARCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERLEUKIN-1 RECEPTOR ANTAGONIST | RANDOMIZED CLINICAL-TRIAL | SECRETORY PHOSPHOLIPASE A | ACUTE CORONARY SYNDROME | APPARENTLY HEALTHY-MEN | REVERSE CHOLESTEROL TRANSPORT | PLACEBO-CONTROLLED TRIAL | TYPE-2 DIABETES-MELLITUS | Hydroxychloroquine - therapeutic use | Interleukin-6 - antagonists & inhibitors | NLR Family, Pyrin Domain-Containing 3 Protein | Colchicine - therapeutic use | Humans | Cell Adhesion Molecules - antagonists & inhibitors | Methotrexate - therapeutic use | Sirtuins - therapeutic use | Vaccination - methods | Lipoproteins, HDL - drug effects | Interleukin-1 - physiology | Interleukin-6 - physiology | Anti-Inflammatory Agents - therapeutic use | Interleukin-1 - antagonists & inhibitors | Leukotriene Antagonists - therapeutic use | Carrier Proteins - physiology | Adaptive Immunity - physiology | Phospholipase A2 Inhibitors - therapeutic use | Atherosclerosis - drug therapy | Serpins - therapeutic use | C-Reactive Protein - physiology | Antioxidants - therapeutic use | Tumor Necrosis Factor-alpha - drug effects | Signal Transduction - drug effects | Tumor Necrosis Factor-alpha - physiology | Thrombosis - drug therapy | Receptors, Interleukin-1 - antagonists & inhibitors | Review
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2016, Volume 75, Issue 4, pp. 644 - 651
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2008, Volume 35, Issue 3, pp. 255 - 261
Summary Drugs that affect microtubule dynamics, including the taxanes and vinca alkaloids, have been a mainstay in the treatment of leukemias and solid tumors... 
Hematology, Oncology and Palliative Medicine | 2-Methoxyestradiol | Discodermolide | Microtubule-targeting agent | Epothilone | Halichondrin B | Microtubule | Taxane | Colchicine | Vinca alkaloid | Taccalonolide | BETA-TUBULIN | VASCULAR DISRUPTING AGENTS | SOLID TUMORS | ANTITUMOR-ACTIVITY | EVERY 28 DAYS | COMBRETASTATIN A4 PHOSPHATE | CELL LUNG-CANCER | BREAST-CANCER | STABILIZING AGENTS | ONCOLOGY | PHASE-I | Colchicine - pharmacology | Taxoids - pharmacology | Tubulin Modulators - pharmacology | Colchicine - therapeutic use | Humans | Epothilones - pharmacology | Epothilones - therapeutic use | Lactones - pharmacology | Drug Delivery Systems | Taxoids - therapeutic use | Neoplasms - genetics | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Microtubules - drug effects | Vinca Alkaloids - pharmacology | Microtubules - ultrastructure | Macrolides - pharmacology | Steroids - pharmacology | Steroids - therapeutic use | Antineoplastic Agents, Phytogenic - therapeutic use | Microtubules - physiology | Clinical Trials as Topic | Vinca Alkaloids - therapeutic use | Cell Division - drug effects | Lactones - therapeutic use | Tubulin Modulators - therapeutic use | Neoplasms - drug therapy | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Antineoplastic Agents, Phytogenic - pharmacology | Macrolides - therapeutic use | Neoplasms - pathology | Drug Screening Assays, Antitumor | Development and progression | Care and treatment | Leukemia | Analysis | Cancer | Index Medicus | Microtubule-Targeting Agent | Vinca Alkyloid
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2017, Volume 166, Issue 1, pp. 58 - 68
Journal Article